Target intelligence / Profile preview

Melanopsin receptor (OPN4)

Target
OPN4
Molecular classification
G protein-coupled receptor, Photoreceptor, Sensory receptor
01

Overview

Melanopsin receptor (OPN4) is a G protein-coupled receptor (GPCR) photopigment encoded by the OPN4 gene and predominantly expressed in intrinsically photosensitive retinal ganglion cells (ipRGCs) of the mammalian retina[1][2][3][4][5]. It plays a crucial role in non-image-forming photoreception, especially the regulation of circadian rhythms by transmitting information about environmental light to the brain's suprachiasmatic nucleus (the master circadian clock)[1][2][4]. Melanopsin is maximally sensitive to blue light (~480 nm), couples predominantly to Gq/11-type G proteins, and activates downstream signaling that results in cellular depolarization and calcium influx—a process distinct from classical rod and cone photoreceptors[1][2][3][5]. Mutations or deficiencies in OPN4 are linked to disorders such as Seasonal Affective Disorder and impairments in circadian entrainment[1][3][4]. Melanopsin's non-visual (photoentrainment, pupillary response) and potential visual (contribution to optokinetic response) functions make it a specialized molecular target in chronobiology and ophthalmology, though there are currently no clinically approved drugs targeting OPN4 directly[3][4][5].

Other names
melanopsinopsin 4OPN4MOPmelanopsin receptormelanopsin-opsinopn4Opsin-4
02

Mechanism of action

Light-dependent activation via G protein-coupled signaling cascade (Gq/11, sometimes Gi/o) leading to membrane depolarization and increase in intracellular calcium[1][2][3][5]

03

Biological functions

Signal transductionRegulation of circadian rhythmNon-image-forming light detectionPupillary light reflexPhotoentrainment of biological clock
04

Disease associations

Seasonal affective disorderSleep disorders (e.g., idiopathic hypersomnia)Other circadian rhythm-related disorders
05

Safety considerations

Potential for disturbances in circadian rhythm and sleep/wake cycles if modulated[1][3]
06

Biomarkers

Expression level (mutation status) of OPN4 for Seasonal Affective Disorder and circadian rhythm disruptions[1][3][4]

Beyond the preview

Go deeper on Melanopsin receptor (OPN4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanopsin receptor (OPN4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call